“It’s a completely delirious fantasy, relying on data of unknown quality, mixing everything, and mixing treatments for which the administered dosages are unknown.”
“How could you imagine that a foolish study relying on big data could change what we have seen by ourselves. We have done 10,000 ECGs here, all of them have been seen by a professor in heart rhythm, i.e. a cardiologist who specializes in the electrical analysis of the heart.”
We have finished our first large study with over 3,600 patients, which allows us to have a clear view of what’s going on. The majority of our patients were treated with the association of hydroxychloroquine and azithromycin.”
“Within that group, the case fatality rate was 0.5%. This is the lowest in the world.”
“Administration of the HCQ+AZ combination before COVID-19 complications occur is safe and associated with very low fatality rate in patients.”
In a nutshell, early treatment with hydroxychloroquine and azithromycin was provided. 98.7% of patients were cured, with 91.7% cured within 10 days. There were 8 deaths (0.75%) (74–95 years old), all from respiratory failure, not from cardiac toxicity. Five patients were still hospitalized by April 16 – when the latest update was done.